We analyzed publicly available data from large cohorts of ALL (n = 203; TARGET study) and AML (n = 179; The Cancer Genome Atlas (TCGA) study) patients for a potential link between CDK8 and members of the mTOR pathway. Here, CDK8 is linked to acute myeloid leukemia.